Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 541Neoplasms 388Carcinoma, Non-Small-Cell Lung 327Colorectal Neoplasms 297Lung Neoplasms 238Prostatic Neoplasms 223Carcinoma, Hepatocellular 215Stomach Neoplasms 155Pancreatic Neoplasms 155Leukemia, Myeloid, Acute 142Uterine Cervical Neoplasms 133Multiple Myeloma 130Recurrence 121Rectal Neoplasms 112Ovarian Neoplasms 112Neoplasm Metastasis 107Squamous Cell Carcinoma of Head and Neck 98Head and Neck Neoplasms 93Triple Negative Breast Neoplasms 86Esophageal Neoplasms 84Endometrial Neoplasms 83Glioblastoma 81Small Cell Lung Carcinoma 80Colonic Neoplasms 78Brain Neoplasms 78Melanoma 72Hematologic Neoplasms 66Precursor Cell Lymphoblastic Leukemia-Lymphoma 64Glioma 63Lymphoma 60

Interventions

Radiotherapy 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × HER2-Negative Locally Advanced Breast Cancer × Clear all
NCT06908668 2025-04-03

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
170 enrolled
Breast

HER2-Negative Locally Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡